Evans CJ - Search Results

1

Ligand-induced changes in surface mu-opioid receptor number: relationship to G protein activation?

Zaki PA, Keith DE Jr, Brine GA, Carroll FI, Evans CJ. Zaki PA, et al. Among authors: evans cj. J Pharmacol Exp Ther. 2000 Mar;292(3):1127-34. J Pharmacol Exp Ther. 2000. PMID: 10688632

2

Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors.

Lutfy K, Eitan S, Bryant CD, Yang YC, Saliminejad N, Walwyn W, Kieffer BL, Takeshima H, Carroll FI, Maidment NT, Evans CJ. Lutfy K, et al. Among authors: evans cj. J Neurosci. 2003 Nov 12;23(32):10331-7. doi: 10.1523/JNEUROSCI.23-32-10331.2003. J Neurosci. 2003. PMID: 14614092 Free PMC article.

3

Agonist-induced state of the delta-opioid receptor that discriminates between opioid peptides and opiate alkaloids.

Von Zastrow M, Keith DE Jr, Evans CJ. Von Zastrow M, et al. Among authors: evans cj. Mol Pharmacol. 1993 Jul;44(1):166-72. Mol Pharmacol. 1993. PMID: 8393518

4

Morphine activates opioid receptors without causing their rapid internalization.

Keith DE, Murray SR, Zaki PA, Chu PC, Lissin DV, Kang L, Evans CJ, von Zastrow M. Keith DE, et al. Among authors: evans cj. J Biol Chem. 1996 Aug 9;271(32):19021-4. doi: 10.1074/jbc.271.32.19021. J Biol Chem. 1996. PMID: 8702570 Free article.

5

Mu opioid receptor-like sequences are present throughout vertebrate evolution.

Li X, Keith DE Jr, Evans CJ. Li X, et al. Among authors: evans cj. J Mol Evol. 1996 Sep;43(3):179-84. doi: 10.1007/BF02338825. J Mol Evol. 1996. PMID: 8703083

6

Opioid receptor types and subtypes: the delta receptor as a model.

Zaki PA, Bilsky EJ, Vanderah TW, Lai J, Evans CJ, Porreca F. Zaki PA, et al. Among authors: evans cj. Annu Rev Pharmacol Toxicol. 1996;36:379-401. doi: 10.1146/annurev.pa.36.040196.002115. Annu Rev Pharmacol Toxicol. 1996. PMID: 8725395 Review.

7

mu-Opioid receptor internalization: opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain.

Keith DE, Anton B, Murray SR, Zaki PA, Chu PC, Lissin DV, Monteillet-Agius G, Stewart PL, Evans CJ, von Zastrow M. Keith DE, et al. Among authors: evans cj. Mol Pharmacol. 1998 Mar;53(3):377-84. Mol Pharmacol. 1998. PMID: 9495801

8

Agonist-, antagonist-, and inverse agonist-regulated trafficking of the delta-opioid receptor correlates with, but does not require, G protein activation.

Zaki PA, Keith DE Jr, Thomas JB, Carroll FI, Evans CJ. Zaki PA, et al. Among authors: evans cj. J Pharmacol Exp Ther. 2001 Sep;298(3):1015-20. J Pharmacol Exp Ther. 2001. PMID: 11504798

9

Brain region-specific mechanisms for acute morphine-induced mitogen-activated protein kinase modulation and distinct patterns of activation during analgesic tolerance and locomotor sensitization.

Eitan S, Bryant CD, Saliminejad N, Yang YC, Vojdani E, Keith D Jr, Polakiewicz R, Evans CJ. Eitan S, et al. Among authors: evans cj. J Neurosci. 2003 Sep 10;23(23):8360-9. doi: 10.1523/JNEUROSCI.23-23-08360.2003. J Neurosci. 2003. PMID: 12967998 Free PMC article.

10

Cloning of a delta opioid receptor by functional expression.

Evans CJ, Keith DE Jr, Morrison H, Magendzo K, Edwards RH. Evans CJ, et al. Science. 1992 Dec 18;258(5090):1952-5. doi: 10.1126/science.1335167. Science. 1992. PMID: 1335167

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

482 results

Search Page